{"id":"amg820-and-pembrolizumab","safety":{"commonSideEffects":[{"rate":"3%","effect":"Pneumonitis"},{"rate":"20%","effect":"Diarrhea"},{"rate":"30%","effect":"Fatigue"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"AMG820 and pembrolizumab work by binding to their respective targets, thereby modulating the immune response.","oneSentence":"AMG820 is a monoclonal antibody targeting CD28 and pembrolizumab is a monoclonal antibody targeting PD-1.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T05:54:11.695Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Non-small cell lung cancer"},{"name":"Melanoma"}]},"trialDetails":[{"nctId":"NCT02713529","phase":"PHASE1, PHASE2","title":"Safety and Efficacy Study of AMG 820 and Pembrolizumab Combination in Select Advanced Solid Tumor Cancer","status":"COMPLETED","sponsor":"AmMax Bio, Inc.","startDate":"2016-04-14","conditions":"Pancreatic Cancer, Colorectal Cancer, Non-Small Cell Lung Cancer","enrollment":117}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_1","status":"active","brandName":"AMG820 and pembrolizumab","genericName":"AMG820 and pembrolizumab","companyName":"AmMax Bio, Inc.","companyId":"ammax-bio-inc","modality":"Biologic","firstApprovalDate":"","aiSummary":"AMG820 is a monoclonal antibody targeting CD28 and pembrolizumab is a monoclonal antibody targeting PD-1. Used for Non-small cell lung cancer, Melanoma.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":1},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}